1 September 2021

September: Childhood and Acute myeloid leukaemia Cancers Awareness Month

Evidence suggests that exposure to smoking by family members during pregnancy or exposure to waterpipe and cigarette smoking during their neonatal period is a risk factor for developing cancer. Evidence supports a possible association between maternal smoking during pregnancy with childhood cancers overall, paediatric neuroblastoma, retinoblastoma, certain types of childhood brain tumours and nervous system cancers. Paternal smoking was related to a significantly elevated risk of childhood lymphoblastic leukemia during pregnancy. 
Scientific research has confirmed cigarette smoking to be associated with an increased risk of developing myeloid leukaemia in adults. Smoking may result in an imbalance in the haematopoietic system such as changes in the erythrocyte–leukocyte ratio and composition of mature leukocytes in peripheral blood. Although no detailed biological mechanism has been proposed, a causal link has made the association of the systemic effects of cigarette smoke and the presence of chemicals in cigarette smoke and leukaemia risk, evident.

ENSP Brochure 2021: Ending tobacco epidemic, an essential step for beating cancer

Every year, 3.5 million people in the EU are diagnosed with cancer, and 1.3 million die from it. Over 40% of cancer cases are preventable. Without reversing current trends, it could become the leading cause of death in the EU. In 2020, the Commission released its Europe’s beating cancer plan aiming at reducing the cancer burden for patients, their families and health systems. Tobacco is a great risk factor for cancer, often still unknown and underestimated. Thus, every month in 2021, ENSP dedicates a section of "The Network" to a certain type of cancer and its link to tobacco.

Doctors from Kazakhstan received training within ENSP's European Accreditation Curriculum on Tobacco Treatment 

Following the launch of the ENSP's Tobacco Dependence Treatment Guidelines in Kazakh and Russian (updated version), ENSP and Smokefree Kazakhstan Coalition hosted the first training on treating tobacco dependence for health professionals in Kazakhstan.
The training took place on 24, 25 and 26 August and was attended by a diverse group of medical doctors: pulmonologists, cardiologists, narcologists, psychologists, psychotherapists, and lifestyle medicine specialists. The initiative was welcomed by the WHO with an opening speech of Dr Laura Vremis representing the WHO Country Office in Kazakhstan.
We would like to thank the trainers (Prof Andrey Demin, Dr Charis Girvalaki, Dr Aggelos Mechili, Dr Hani Al Gouhmani), our local organiser, director of the Coalition Jamilya Sadykova for their contributions, and all participants for their interest and intention to incorporate smoking cessation into their medical practice!
To request a training in your country send an inquiry to ENSP Secretariat.
We also invite you to visit ENSP's e-learning platform which is freely available for all healthcare professionals and the public. 
We are confident that the platform will help healthcare professionals to be equipped with the necessary skills to combat this fatal addiction and provide them with a wide range of vital tools in order to help them introduce tobacco treatment delivery into their daily clinical life. ENSP’s online training program provides the opportunity for healthcare professionals in Europe to receive training in the latest evidence-based practices for helping their patients quit smoking.
The ENSP e-learning platform has also received accreditation by the European Accreditation Council for Continuing Medical Education (EACCME)  to provide CME activity for medical specialists.
The platform is being continuously updated with more functionality, tools, additional access languages, and new modules added to the programme. Stay tuned and follow the course in your language this summer via http://elearning-ensp.eu/!

Upcoming events

23 September: symposium "Sex and gender differences in tobacco control"

Men and women often have different reasons for smoking and experience different obstacles when attempting to quit. As researchers and health providers, it is important to pay attention to these differences in order to address existing disparities in smoking and quitting. But what are these differences exactly? And how can we address them?


The symposium "Sex and gender differences in tobacco control" will be held online, on 23 September 2021, from 15:00 to 16:30 CEST. During this event, a range of topics concerning sex/gender differences and issues in tobacco control will be covered, such as differences in the triggers and barriers to quit smoking and the effectiveness of national-level interventions.

  • Prof. dr. Gera Nagelhout, Maastricht University and IVO Research Institute - ' Sex/gender differences in triggers for thinking about quitting smoking: Findings from the International Tobacco Control (ITC) Netherlands Survey
  • Dr. Hedwig Vos, Leiden University Medical Centre - ‘ Gender differences within the barriers to smoking cessation
  • Nikita Poole, MSc, Maastricht University and IVO Research Institute - ‘ How do sex, age and educational level influence the potential impact of national smoking cessation mass media campaigns? Findings from the 2008–2017 International Tobacco Control (ITC) Netherlands Surveys
  • Dr. Rachel O'Donnell, University of Stirling - ‘ Shifting roles and expectations: The need to better engage fathers in smoke-free home interventions
  • Dr. MacKenzie Peltier, Yale University - ‘ Tobacco Use Among Females: Looking Across the Menopausal Transition

5-7 November: The third (virtual) ELMO Congress

The European Lifestyle Medicine Organization (ELMO) is a scientific, medical organization based in Geneva (Switzerland), dedicated to research, prevention and treatment of chronic diseases and lifestyle related diseases and promoting evidence-based medicine. As a founding member of the Global Lifestyle Alliance, it counts more than 40 partners globally.

This year, ELMO will be hosting the 3rd ELMO Congress virtually between the 5th – 7th of November 2021. Therefore, you can already register as a participant, or submit your abstract. All ENSP members wishing to register for the congress have a 10% discount in the standard registration form by using the code ensp2021.

8-13 November and 15-18 November: Registration is now open for COP9 and MOP2 and their provisional agendas are published

The Convention Secretariat has released the first group of documents, including the provisional agendas and the instructions to register for the Ninth Session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control and the Second Session of the Meeting of the Parties to the Protocol to Eliminate Illicit Trade in Tobacco Products.


In view of the COVID-19 global pandemic and its impact on the conduct of global conferences and travel, it has not been feasible to organize a face-to-face sessions in The Hague, Netherlands, as initially planned for the Ninth Session of the Conference of the Parties (COP9) to the WHO Framework Convention on Tobacco Control (WHO FCTC) and the Second Session of the Meeting of the Parties (MOP2) to the Protocol to Eliminate Illicit Trade in Tobacco Products. Therefore, both meetings will take place virtually, with COP9 running from 8 to 13 November 2021 and MOP2 from 15 to 18 November 2021.

Other news and publications

New STOP Report

Driving Addiction: Tobacco Sponsorship in Formula One


The tobacco industry is always looking for creative ways to market and addict new users. One of its current aims: spending millions to market its brands and corporate messages in Formula 1 (F1)–a sports series known to have a young fanbase.


Last year, STOP released a report detailing how Formula 1 continues to allow tobacco sponsorships. The main idea was to expose how tobacco companies strategically exploit F1’s failure to enforce its ban on tobacco advertising—unlike most other sports—ultimately exposing millions of fans to the industry’s messaging.

For the 2021 season, a new report entitled Driving Addiction: Tobacco Sponsorship in Formula One, 2021 has been published and it reveals how the industry is exploiting broadcast media, social media, e-sports and more to reach an increasingly young F1 fan base. In fact, 36% of F1’s new fans are 25 years old or younger.

Get involved!

Sign on Letter Campaign to stop PMI's collaboration  with the Spanish local government

PMI is currently funding a small community in the Canary Islands, La Graciosa's initiative, to earn a "smoke-free culture" certification from TÜV AUSTRIA (a certification previously awarded only once and whose requirements include offering alternatives to cigarettes). 
The Spanish tobacco control community, led by the Comité Nacional Contra la Prevención del Tabaquismo/National Committee for the Prevention of Smoking (CNPT) and Nofumadores.org, has developed this letter campaign requesting local, regional and national branches of the Spanish Government to call for an end of the La Gracisosa's partnership with Philip Morris International.

The letter has been signed by more than 60 Spanish NGOs and coalitions of NGOs and is already supported by over 50 additional organisations from around the world. The ENSP encourages all its members and partners to sign on to this letter campaign and support our Spanish colleagues.

Now also indexed in PubMed Central. Learn more...

The latest publications in the TPC Journal:
Gail Hurley
Katy Ellis Hilts, Justin Blackburn, P. Joseph Gibson, Valerie A. Yeager, Paul K. Halverson, Nir Menachemi
Ngiap C. Tan, Yi L. E. Koh, Chin C. Goh, Soh H. A. Ngoh, Ai M. Tan, Usha Sankari, Seng B. Lee, Hong C. D. Tay, Soon H. Lim
Rajmohan Panda, Divya Persai, Sandeep Mahapatra, Itismita Mohanty
Marina Istrate, Mihai Hasbei-Popa, Daniela A. Iliescu, Ana C. Ghita, Aurelian M. Ghita
Do you have an event coming up or news to celebrate? 
Would you like to share your best practices or inform about local initiatives?

Share your work and promote you activities among 2.400+ colleagues in Europe and around the globe via 
The Network - ENSP monthly newsletter
vaping360.com/iqos-philip-morris//e-cigarettes/ (Vaping360)
View this email in your browser
You are receiving this email because of your relationship with ENSP. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent to alise.krumina@gmail.com by cornel.radu@ensp.org
Chaussée d'Ixelles 144 Ixelles Brussels Belgium

Unsubscribe from all mailings Unsubscribe | Manage Subscription | |

This is a Test Email only.
This message was sent for the sole purpose of testing a draft message.